Public Hearings

Agenda 

Highlights and recommendations from the 2024 Drug Price Transparency Report

• Agency presentation of the 2024 Drug Price Transparency Report to the Oregon Legislature

Drug advertising

• Invited presenters to speak about who really pays for drug advertising and whether what you see is what you get.

Drug rebates

• Invited presenters to speak about why rebates are necessary, how they help or harm the consumer, and how they affect what drugs are available.
  

There will be opportunities for public comment. Insurance Commissioner Andrew Stolfi will facilitate the hearing, and Oregon legislators will ask questions and lead discussions about the panel presentations.

Public testimony

We encourage you to testify at the hearing or provide written testimony. Contact us at rx.prices@dcbs.oregon.gov for any questions you have about sharing your story or the public hearing.

• Testimony: American Association of Retired People (AARP Oregon)
• Testimony: medication affordability
• Testimony: Obesity Action Coalition (OAC)
• Testimony: Oregon Nurses Association (ONA) and Oregon Coalition for Affordable Prescriptions (OCAP)
• Testimony: pharmacy patient experiences
• Testimony: regarding presentations at hearing

Share your stories

The Oregon Department of Consumer and Business Services is asking for the public's help before the 2024 public hearing on prescription drug prices. The department has set up a brief survey for consumers to share their stories about rising prescription drug prices. Drug prices play a major role in the health care decisions of Oregonians, and the cost of prescription drugs have steadily increased. The department wants to hear your stories about the increased costs of prescription drug prices and how they have affected you and your family.